European urology · 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Patrikidou Anna, Cazzaniga Walter, Oing Christoph, Berney Daniel, Lobo Joao, Boormans Joost, Fankhauser Christian, Fischer Stefanie, Leao Ricardo, Gravina Carmen, Nardo Domenico Di, Cornes Robert, Janisch Florian, Bezuidenhout Carla, Haugnes Hege Sagstuen, Papachristofilou Alexandros, Tandstad Torgrim, Heidenreich Axel
Аннотация
BACKGROUND AND OBJECTIVE: The European Association of Urology (EAU) produces an annual guidelines document based on the most recent evidence for the diagnosis, treatment, and follow-up of testicular cancer (TC). To summarize the 2026 version of the EAU Guidelines on TC and highlight the main changes compared to the previous version.
METHODS: A multidisciplinary team of clinicians with specific expertise in the disease (urologists, medical oncologists, radiation oncologists, and pathologists) reviewed the results of a comprehensive appraisal of the published literature on the topic since the last Guidelines update paper in 2023.
KEY FINDINGS AND LIMITATIONS: Recommendations based on the highest available level of evidence are presented across TC stages, histologies and prognostic categories regarding diagnosis, primary management, detection and treatment of relapse and survivorship care. Areas of lack of strong recommendation consensus are highlighted.
CONCLUSIONS AND CLINICAL IMPLICATIONS: The 2026 version of the EAU Guidelines on TC collates the highest available scientific evidence to standardize the management of patients with TC.
METHODS: A multidisciplinary team of clinicians with specific expertise in the disease (urologists, medical oncologists, radiation oncologists, and pathologists) reviewed the results of a comprehensive appraisal of the published literature on the topic since the last Guidelines update paper in 2023.
KEY FINDINGS AND LIMITATIONS: Recommendations based on the highest available level of evidence are presented across TC stages, histologies and prognostic categories regarding diagnosis, primary management, detection and treatment of relapse and survivorship care. Areas of lack of strong recommendation consensus are highlighted.
CONCLUSIONS AND CLINICAL IMPLICATIONS: The 2026 version of the EAU Guidelines on TC collates the highest available scientific evidence to standardize the management of patients with TC.